Evidence map›Paper›PMID 31440525›Full record

ArticleTobacco regulatory science2018

"Who's Really Regulating? Who's Benefiting?" Exploring Black Stakeholders' Awareness and Trust in the Food and Drug Administration's Role as a Tobacco Regulator.

Sabrina L Smiley, Kacie C A Blackman, Ricky N Bluthenthal, Yaneth L Rodriguez, Rosa Barahona, Steve Sussman, Mary Ann Pentz, Jonathan M Samet, Lourdes Baezconde-Garbanati

Abstract read
In one paragraph

Article in Tobacco regulatory science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sabrina L SmileyUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Kacie C A BlackmanUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Ricky N BluthenthalUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Yaneth L RodriguezUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Rosa BarahonaUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Steve SussmanUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Mary Ann PentzUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.
Jonathan M SametColorado School of Public Health, Denver, CO.
Lourdes Baezconde-GarbanatiUniversity of Southern California Tobacco Center of Regulatory Science for Vulnerable Populations, Keck School of Medicine, Los Angeles, CA.

Funding

USC Tobacco Center of Regulatory ScienceU54CA180905 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Jessica Louise Barrington-Trimis · 2018 to 2026
$39.0M
USC Tobacco Center of Regulatory Science (TCORS) for Vulnerable PopulationsP50CA180905 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PENTZ, MARY ANN, SAMET, JONATHAN M · 2013 to 2017
$20.1M
NCI NIH HHS P50 CA180905NCI NIH HHS U54 CA180905
6 · The paper itself

Abstract

objectiveBlacks/African Americans have experienced direct public health harm from US governmental agencies (eg, police violence, Tuskegee syphilis experiment) that may influence perceptions of the trustworthiness of government messages regarding tobacco products. Consequently, we sought to explore Black Americans' awareness of and trust in the FDA's role as a tobacco regulator.

methodsData were from 2 focus groups conducted with a purposive sample of 23 Black stakeholders in Los Angeles, California. Discussions were audio-recorded and transcribed verbatim for analysis.

resultsAlthough most (N = 14; 61%) participants were aware of the FDA's role as a tobacco regulator, they all noted that the Black community in Los Angeles is not aware. Recurrent across the focus groups were discussions about distrust in the FDA with 4 main contributing factors: (1) that the FDA is influenced by the tobacco, agricultural, and pharmaceutical industries; (2) that the FDA is influenced by money and politics; (3) that the FDA is a bureaucracy exercising monopoly and power; and (4) that the FDA lacks technical capacity and competence to regulate tobacco products.

conclusionsStudy findings highlight opportunities for the FDA to increase awareness and build trust in their tobacco regulatory role through communication campaigns targeted at Black Americans, and community engagement with Black stakeholders.

Indexed as

black AmericansFood and Drug Administrationqualitative researchstakeholderstobacco regulationtrust

Identifiers

PMID31440525
PMCPMC6705425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.